NCT07094776View on ClinicalTrials.gov

Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study

Enrolling by invitationOBSERVATIONAL
Enrollment

128

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

August 20, 2025

Study Completion Date

August 20, 2025

Conditions
Polycystic Ovary Syndrome (PCOS)Insulin Resistance Syndrome
Interventions
OTHER

No intervention (observational study)

This is an observational study. No drugs, devices, or treatments are administered. Participants only provide a single blood sample for MG53 and routine metabolic measurements.

Trial Locations (1)

34255

University of Health Sciences, Gaziosmanpaşa Training and Research Hospital, Gaziosmanpaşa

All Listed Sponsors
lead

Havva Betül Bacak

OTHER_GOV